COR Cencora, Inc. stock chart & analysis
Conviction 65HealthcareScan · Fri, Nov 6, 2026Cencora, Inc. (COR) closed at $333.56 (-1.80%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 52, RS Rating 60, -11.7% from its 52-week high, -1.3% year to date. Sector: Healthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Financials as of Tue, Jun 30, 2026 · quarterly.
COR technical analysis
Trend
COR is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 2.6% above the 50-day ($325.11) and 5.3% above the 200-day ($316.79). ADX(14) at 22 points to a moderate trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 52, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 60 puts its weighted 12-month performance ahead of about 60% of the US market.
Volume and volatility
Volume on the latest session ran 1.0× its 20-day average. It trades about $473.8M a day on average. ATR(14) is $9.24, 2.8% of price — its typical daily range. Chaikin Money Flow (-0.05) shows distribution.
Key levels
The chart pattern's support is $299.73 and its resistance $345.23. The 52-week range is $244.82 to $377.54; price is 11.7% below the high and 36.2% above the low. The VWAP anchored at the 52-week high is $316.44, below price.
Performance
COR returned +0.8% (1 week), +3.8% (1 month), +2.6% (3 months), +27.8% (6 months), -5.8% (1 year), -1.3% (year to date).
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Listed 1995 · 51,000 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upSep 141 scan
- Broke outOct 131 scan
Recent news
- Cencora, Inc.: 8-K filedSEC EDGAR · Wed, Nov 4, 2026
- Cencora, Inc.: Earnings resultsSEC EDGAR · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in COR · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Jared Moskowitz house · D · FL · traded 2026-05-06 | Sell | $1K–$15K | 2026-05-06 | 2026-06-19 | |
Jared Moskowitz house · FL · traded 2026-03-23 | Buy | $1K–$15K | 2026-03-23 | 2026-03-31 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $50K–$100K | 2025-05-12 | 2025-06-22 | |
 Greg Landsman house · D · OH · traded 2025-03-27 | Sell | $15K–$50K | 2025-03-27 | 2025-04-08 |
Insider activity
SEC Form 4 transactions in COR · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Krikorian Lazarus SVP & Chief Accounting Officer · Common Stock · 2026-11-02 | Sell | 986 | $326K | 2026-11-02 | 2026-11-03 |
Tyler Lauren M Director · Common Stock · 2026-10-30 | Grant | 91 | $30K | 2026-10-30 | 2026-11-03 |
Cooper Ellen Director · Common Stock · 2026-10-30 | Grant | 91 | $30K | 2026-10-30 | 2026-11-03 |
Verma Pawan EVP, Chief Data & Info Officer · Common Stock · 2026-10-30 | Exercise | 8.54K | — | 2026-10-30 | 2026-11-03 |
Verma Pawan EVP, Chief Data & Info Officer · Common Stock · 2026-10-30 | Tax | 4.25K | $1.4M | 2026-10-30 | 2026-11-03 |
Verma Pawan EVP, Chief Data & Info Officer · Restricted Stock Units · 2026-10-30 | Exercise | 8.54K | — | 2026-10-30 | 2026-11-03 |
NALLY DENNIS M Director · Common Stock · 2026-10-30 | Grant | 106 | $35K | 2026-10-30 | 2026-11-03 |
Krikorian Lazarus SVP & Chief Accounting Officer · Common Stock · 2026-10-01 | Sell | 986 | $299K | 2026-10-01 | 2026-10-05 |
SANCHEZ ROBERT E Director · Common Stock · 2026-10-01 | Grant | 275 | — | 2026-10-01 | 2026-10-05 |
GREENBERG LON R Director · Common Stock · 2026-09-16 | Sell | 1.28K | $411K | 2026-09-16 | 2026-09-17 |
SEC filings
EDGAR filings in COR · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.